Sigma Factor Binding

Sigma factor binding is the interaction through which bacterial sigma factors associate with RNA polymerase and direct it to specific promoter sequences, making it central to transcriptional regulation and rapid gene-expression changes. A sigma factor recognizes promoter elements, commonly the −35 and −10 regions, while bound to the core RNA polymerase; this complex forms the transcription-initiation complex, locally unwinds DNA, and begins RNA synthesis before the sigma factor is released or exchanged. Studying sigma factor binding helps explain bacterial responses to stress, nutrient limitation, and development, and supports promoter annotation, gene-regulatory network analysis, and efforts to understand or manipulate microbial physiology.

Sigma Factor Binding - Related Videos

Research

JoVE Journal - Biology
Free Sample

Sigma's Non-specific Protease Activity Assay - Casein as a Substrate

0 Views •

Cited by 412 •

2008

Proteases break peptide bonds. In the lab, it is often necessary to measure and/or compare the activity of proteases. Sigma's non-specific protease activity assay may be used as a standardized procedure to determine the activity of proteases.

Education

JoVE Core - Pharmacokinetics and Pharmacodynamics

Factors Affecting Protein-Drug Binding: Drug-Related Factors

0 Views •

2025

Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body. One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...

Factors Affecting Protein-Drug Binding: Patient-Related Factors

0 Views •

2025

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects. Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...

Factors Affecting Protein-Drug Binding: Protein-Related Factors

0 Views •

2025

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process. The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...

Fluorescence Anisotropy to Determine Transcription Factor-DNA Binding Affinity

0 Views •

2025

This video describes high-performance fluorescence anisotropy that helps to monitor the interaction between transcription factors and DNA. The assay monitors the interactions of a fluorophore-labeled DNA molecule with its specific transcription factor by measuring the degree of polarization due to molecular rotation or anisotropy of the fluorophore-labeled DNA.

View All Results

FAQs

Related Topics